Tanaka F - Search Results

1

Frequency of epidermal growth factor receptor mutations in Bangladeshi patients with adenocarcinoma of the lung.

Rahman S, Kondo N, Yoneda K, Takuwa T, Hashimoto M, Orui H, Okumura Y, Tanaka F, Kumamoto K, Mostafa MG, Chowdhury GM, Haque A, Hasegawa S. Rahman S, et al. Among authors: tanaka f. Int J Clin Oncol. 2014 Feb;19(1):45-9. doi: 10.1007/s10147-012-0515-4. Epub 2013 Jan 9. Int J Clin Oncol. 2014. PMID: 23299280

2

Prognostic value of thymidylate synthase expression in patients with p-stage I adenocarcinoma of the lung.

Nakagawa T, Tanaka F, Otake Y, Yanagihara K, Miyahara R, Matsuoka K, Takata T, Yamada T, Fukushima M, Wada H. Nakagawa T, et al. Among authors: tanaka f. Lung Cancer. 2002 Feb;35(2):165-70. doi: 10.1016/s0169-5002(01)00407-x. Lung Cancer. 2002. PMID: 11804689

3

Clinical significance of p21 expression in non-small-cell lung cancer.

Shoji T, Tanaka F, Takata T, Yanagihara K, Otake Y, Hanaoka N, Miyahara R, Nakagawa T, Kawano Y, Ishikawa S, Katakura H, Wada H. Shoji T, et al. Among authors: tanaka f. J Clin Oncol. 2002 Sep 15;20(18):3865-71. doi: 10.1200/JCO.2002.09.147. J Clin Oncol. 2002. PMID: 12228206

4

Lung cancer-related genes in the blood.

Sonobe M, Tanaka F, Wada H. Sonobe M, et al. Among authors: tanaka f. Ann Thorac Cardiovasc Surg. 2004 Aug;10(4):213-7. Ann Thorac Cardiovasc Surg. 2004. PMID: 15458371 Review.

5

Matrix metalloproteinase-2 status in stromal fibroblasts, not in tumor cells, is a significant prognostic factor in non-small-cell lung cancer.

Ishikawa S, Takenaka K, Yanagihara K, Miyahara R, Kawano Y, Otake Y, Hasegawa S, Wada H, Tanaka F. Ishikawa S, et al. Among authors: tanaka f. Clin Cancer Res. 2004 Oct 1;10(19):6579-85. doi: 10.1158/1078-0432.CCR-04-0272. Clin Cancer Res. 2004. PMID: 15475447

6

Surgery for pulmonary nodules in breast cancer patients.

Tanaka F, Li M, Hanaoka N, Bando T, Fukuse T, Hasegawa S, Wada H. Tanaka F, et al. Ann Thorac Surg. 2005 May;79(5):1711-4; discussion 1714-5. doi: 10.1016/j.athoracsur.2004.10.033. Ann Thorac Surg. 2005. PMID: 15854960

7

Prognostic significance of reversion-inducing cysteine-rich protein with Kazal motifs expression in resected pathologic stage IIIA N2 non-small-cell lung cancer.

Takenaka K, Ishikawa S, Yanagihara K, Miyahara R, Hasegawa S, Otake Y, Morioka Y, Takahashi C, Noda M, Ito H, Wada H, Tanaka F. Takenaka K, et al. Among authors: tanaka f. Ann Surg Oncol. 2005 Oct;12(10):817-24. doi: 10.1245/ASO.2005.09.018. Epub 2005 Aug 8. Ann Surg Oncol. 2005. PMID: 16132376

8

Pulmonary sclerosing hemangioma with metastasis to the mediastinal lymph node.

Katakura H, Sato M, Tanaka F, Sakai H, Bando T, Hasegawa S, Nakashima Y, Wada H. Katakura H, et al. Among authors: tanaka f. Ann Thorac Surg. 2005 Dec;80(6):2351-3. doi: 10.1016/j.athoracsur.2004.06.099. Ann Thorac Surg. 2005. PMID: 16305908

9

Lung adenocarcinoma harboring mutations in the ERBB2 kinase domain.

Sonobe M, Manabe T, Wada H, Tanaka F. Sonobe M, et al. Among authors: tanaka f. J Mol Diagn. 2006 Jul;8(3):351-6. doi: 10.2353/jmoldx.2006.050132. J Mol Diagn. 2006. PMID: 16825508 Free PMC article.

10

Recurrence of bilateral diffuse bronchiectasis after bilateral lung transplantation.

Chen F, Hasegawa S, Bando T, Kitaichi M, Hiratsuka T, Kawashima M, Hanaoka N, Yoshimura T, Tanaka F, Trulock EP, Wada H. Chen F, et al. Among authors: tanaka f. Respirology. 2006 Sep;11(5):666-8. doi: 10.1111/j.1440-1843.2006.00904.x. Respirology. 2006. PMID: 16916346

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,662 results

Search Page